Chemoinformaics analysis of 11-beta-acetoxygedunin
| Molecular Weight | 498.572 | nRot | 2 |
| Heavy Atom Molecular Weight | 464.3 | nRig | 31 |
| Exact Molecular Weight | 498.225 | nRing | 6 |
| Solubility: LogS | -4.596 | nHRing | 3 |
| Solubility: LogP | 3.327 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 70 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 5 |
| nHA | 8 | APOL | 75.847 |
| nHD | 1 | BPOL | 43.657 |
| QED | 0.486 |
| Synth | 5.777 |
| Natural Product Likeliness | 3.527 |
| NR-PPAR-gamma | 0.074 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.998 |
| Pgp-sub | 0.259 |
| HIA | 0.015 |
| CACO-2 | -5.387 |
| MDCK | 0.0000141 |
| BBB | 0.854 |
| PPB | 0.819295 |
| VDSS | 1.947 |
| FU | 0.185851 |
| CYP1A2-inh | 0.011 |
| CYP1A2-sub | 0.119 |
| CYP2c19-inh | 0.05 |
| CYP2c19-sub | 0.388 |
| CYP2c9-inh | 0.331 |
| CYP2c9-sub | 0.024 |
| CYP2d6-inh | 0.034 |
| CYP2d6-sub | 0.04 |
| CYP3a4-inh | 0.863 |
| CYP3a4-sub | 0.658 |
| CL | 5.719 |
| T12 | 0.274 |
| hERG | 0.063 |
| Ames | 0.058 |
| ROA | 0.868 |
| SkinSen | 0.195 |
| Carcinogencity | 0.36 |
| EI | 0.025 |
| Respiratory | 0.975 |
| NR-Aromatase | 0.327 |
| Antiviral | Yes |
| Prediction | 0.842765 |